A Study to Evaluate the Safety and Efficacy of CB-03-01 Cream, 1% in Subjects With Facial Acne Vulgaris (26)
Status:
Completed
Trial end date:
2018-02-21
Target enrollment:
Participant gender:
Summary
The primary objective of this study is to determine the safety and efficacy of CB-03-01
cream, 1%, versus the vehicle cream applied twice daily for 12 weeks in subjects with facial
acne vulgaris.